Description
Tirzepatide is a dual agonist that engages both the GIP and GLP-1 receptors. By acting on two metabolic receptor pathways at once, it has become a notable compound in laboratory research on energy and glucose handling.
Research interest in Tirzepatide centers on glucose metabolism, appetite regulation, and broader metabolic signaling. It is provided as a 30mg lyophilized powder per vial for experimental use.
Supplied for research, laboratory, and analytical purposes only. Human or animal consumption is prohibited.
Reviews
There are no reviews yet.